U.S. Online Retail and Ecommerce Stock News

O-I Glass (OI) opened 2026 with Q1 revenue of US$1.5b and a basic EPS loss of US$0.48, while trailing twelve month revenue stood at US$6.4b alongside a TTM basic EPS loss of US$1.21. Over recent quarters, revenue has moved within a tight band from US$1.5b to US$1.7b, while quarterly basic EPS has swung between a profit of US$0.20 and a loss of US$1.00. As a result, the latest results keep the focus firmly on how quickly margins can improve from here. See our full analysis for O-I Glass. With...

Flushing Financial (FFIC) opened Q1 2026 with trailing twelve month revenue of US$226.1 million and basic EPS of US$0.54, framing a return to profitability after prior losses that were shaped by a one off loss of US$17.6 million. Over recent quarters the company has seen quarterly revenue move between US$50.2 million and US$59.3 million, while basic EPS has ranged from a loss of US$1.63 per share to a profit of US$0.41 per share. This gives investors a clearer view of how earnings have reset...

Two Harbors Investment (TWO) opened 2026 with Q1 revenue of US$87.6 million and basic EPS of US$0.18, setting a cleaner starting point after a volatile run of quarterly results. The company has seen revenue move from US$7.9 million in Q1 2025 to US$87.6 million in Q1 2026, while quarterly EPS has swung from a loss of US$0.89 in early 2025 to a profit of US$0.18. This puts the latest numbers in sharp contrast to the weak trailing 12 month loss of US$3.77 per share. For investors, this mix of...

Archer-Daniels-Midland has recently outperformed the wider Consumer Staples sector, with analysts raising their earnings estimates as the company’s operations show relative strength versus both sector and Agriculture – Operations peers. This improved analyst sentiment highlights how ADM’s mix of agriculture processing and higher-margin ingredients is currently standing out within a typically defensive sector. We’ll now examine how ADM’s recent analyst upgrades and sector outperformance may...

Albemarle Corporation recently announced that long-serving Chief Accounting Officer Donald J. LaBauve Jr. will retire on June 1, 2026, after more than 36 years with the company, with the departure explicitly not tied to any disagreement over accounting or financial reporting. At the same time, Albemarle has drawn heightened investor attention as analysts have significantly raised near-term earnings estimates, reflecting a very large projected year-over-year increase in expected quarterly...

Renasant (RNST) opened Q1 2026 with total revenue of US$265.8 million and basic EPS of US$0.94, alongside trailing twelve month revenue of US$978.3 million and EPS of US$2.41 that set the backdrop for the latest print. Over recent quarters, revenue has moved from US$165.9 million in Q1 2025 to US$265.8 million in Q1 2026, while quarterly EPS has ranged from US$0.01 in Q2 2025 to US$0.94 in the latest period, giving investors a clearer view of how profitability is flowing through the income...

Anika Therapeutics (ANIK) closed Q4 2025 with total revenue of about US$30.6 million and basic EPS of US$0.13, setting the stage for Q1 2026 after a year in which trailing twelve month revenue reached roughly US$112.8 million and basic EPS on that basis was a loss of US$0.70. Over recent quarters the company has seen revenue move from US$26.2 million in Q1 2025 to US$30.6 million in Q4 2025, while basic EPS shifted from a loss of US$0.28 to a profit of US$0.13. This highlights a quarter that...

Johnson & Johnson has launched a head to head clinical trial comparing its Varipulse Pro pulsed field ablation system with Boston Scientific's FARAPULSE platform. Boston Scientific's recent acquisition of Penumbra has raised questions around valuation, integration risks and potential pressure on its core pulsed field ablation business. Boston Scientific, NYSE:BSX, is in focus as competitive and deal related headlines converge on its core pulsed field ablation franchise. The shares trade at...

Tennant recently reported that customers postponing equipment purchases have contributed to a 1.6% annual revenue decline over the past two years, with earnings per share falling even faster and returns on capital weakening. This combination of softer demand and shrinking profitability per sale suggests the company is finding it harder to generate value from its existing operations. We’ll now examine how Tennant’s reduced earnings per share and returns on capital may reshape the company’s...

NeoGenomics (NEO) opened Q1 2026 with revenue of US$186.7 million, a basic EPS loss of US$0.13, and net income loss of US$17.1 million, setting a clear tone for how the year is starting after recent quarters of negative earnings. Over recent periods, the company has seen quarterly revenue move from US$172 million in Q4 2024 to US$168.0 million in Q1 2025 and US$181.3 million in Q2 2025, while quarterly EPS has remained in loss territory across the same stretch. The latest print therefore...

Ionis Pharmaceuticals (IONS) opened 2026 with Q1 results that keep the focus firmly on its path to profitability, following 2025 figures that included Q4 revenue of US$203.3 million, a basic EPS loss of US$1.42, and a full year of trailing twelve month revenue of US$943.7 million against a net loss of US$381.4 million. Over recent quarters, the company has seen revenue move from US$131.6 million in Q1 2025 to US$452.0 million in Q2 2025, US$156.7 million in Q3 2025, and US$203.3 million in Q4...

IDEX (IEX) just turned in its Q1 2026 scorecard, with recent quarterly revenue moving from US$798.2 million in Q3 2024 to US$899.1 million in Q4 2025. Over the same stretch, basic EPS ranged from US$1.26 in Q1 2025 to around US$1.74 in Q2 2025. During this period, trailing twelve month revenue was about US$3.5 billion at Q4 2025, with basic EPS of US$6.42. This gives investors a clearer view of how top line scale and per share earnings have been tracking ahead of this latest update and...

LXP Industrial Trust (LXP) opened Q1 2026 with trailing twelve month revenue of US$350.2 million and basic EPS of US$1.82, setting a clear benchmark for how its income statement is tracking into the new year. Over recent periods, revenue has moved from US$358.5 million at the end of 2024 to US$361.1 million and then US$364.3 million, while EPS shifted from US$0.65 to US$0.98 and then US$1.90. This gives investors a concrete view of how the top and bottom lines have evolved alongside improving...

DigitalBridge Group (DBRG) opened 2026 with Q1 total revenue of US$72.2 million and basic EPS of US$0.06, alongside trailing twelve month revenue of US$120.7 million and EPS of US$0.53. Over the past few quarters, revenue has ranged from US$3.8 million to US$72.2 million, while basic EPS has moved between a loss of US$0.08 per share in Q4 2024 and earnings of US$0.29 per share in Q4 2025. This gives investors a wide band of recent earnings outcomes to compare against the latest print. With...

Unum Group (UNM) opened 2026 with Q1 revenue of about US$3.4b and basic EPS of US$1.41 on net income of US$232m, setting the tone for how investors will read the rest of the year. Over recent quarters, the company has seen revenue move between US$3.1b and US$3.4b while quarterly basic EPS has ranged from US$0.23 to US$1.93, giving investors a clear view of how earnings power tracks alongside a relatively steady top line. With trailing 12 month EPS at US$4.62 and net profit margins recently...

AerCap Holdings (AER) opened 2026 with Q1 results set against a strong recent run of profitability, backed by trailing 12 month net income of US$3.8b and basic EPS of US$21.78 as the shares trade around US$138.11. Over the last few reported quarters, the company has seen quarterly revenue range between about US$1.9b and US$2.3b, while basic EPS moved from US$3.58 to US$7.24 and US$7.09 before landing at US$3.86 in Q4 2025. This gives investors plenty to weigh around the quality and...

Yum China Holdings (NYSE:YUMC) opened 2026 with Q1 results that keep the focus firmly on the top and bottom line, with quarterly revenue of US$2.8b and basic EPS of US$0.39, alongside trailing twelve month revenue of US$11.8b and EPS of US$2.52. Over recent quarters, the company has seen revenue range between US$2.6b and US$3.2b, while quarterly EPS has moved between US$0.30 and US$0.78. This gives investors a broad view of how earnings have tracked through different trading conditions as...

Seven Hills Realty Trust (SEVN) has just released its latest results, with recent quarterly revenue sitting at about US$7.9 million and basic EPS of roughly US$0.29, set against a trailing 12 month basic EPS of about US$1.00 and revenue of around US$29.2 million. Over the last few reported quarters, revenue has moved between roughly US$6.5 million and US$10.5 million while basic EPS has ranged from about US$0.18 to US$0.33. This gives investors a clearer view of how the income stream has...

ABM Industries (ABM) shares are in focus after the company was selected by Vanderbilt University to deliver its ABM Performance Solutions model at the institution’s New York City campus. See our latest analysis for ABM Industries. The Vanderbilt contract lands at a time when ABM’s 1 month share price return of 5.02% contrasts with a weaker 90 day share price return of 13.09% and a 1 year total shareholder return of 16.29%. This suggests recent momentum is still trying to rebuild after a...

Agios Pharmaceuticals (AGIO) has opened Q1 2026 earnings season with a recent run of quarterly results that show total revenue of $19.97 million in Q4 2025 and a basic EPS loss of $1.85, alongside trailing twelve month revenue of $54.03 million and a basic EPS loss of $7.12. Over the past six reported quarters, the company has seen quarterly revenue move between $8.73 million and $19.97 million, while basic EPS has ranged from a loss of $1.55 to a one off positive print of $16.65, giving...

Navient (NAVI) opened Q1 2026 earnings season with Q4 2025 revenue of US$93 million and a basic EPS loss of US$0.05, as net income excluding extra items came in at a loss of US$5 million. Over recent quarters, the company has seen revenue move from US$206 million in Q4 2024 to US$126 million, US$119 million, and then US$93 million. Over the same period, basic EPS shifted from a profit of US$0.23 in Q4 2024 to a mix of small profits and losses, including a US$0.88 loss in Q3 2025. For...

Central Pacific Financial (CPF) opened 2026 with Q1 results set against a trailing 12 month record that includes US$276.9 million in revenue and basic EPS of US$2.88, with earnings up 45.1% year over year and net profit margin improving from 22.2% to 28.0%. Over the past year, revenue has moved from US$240.6 million to US$276.9 million while EPS has gone from US$1.97 to US$2.88, giving investors a clear view of how the income line has tracked alongside top line growth. With that backdrop, the...

Investors may be wondering whether Macy's current share price still offers value after a strong run, or if most of the opportunity has already been priced in. The stock closed at US$19.30, with a 7 day return of a 4.5% decline, a 30 day return of 9.8%, a year to date return of a 15.2% decline, and a 1 year return of 76.8%. This gives you a mix of recent pullbacks and strong longer term gains to consider. Recent headlines have focused on Macy's as a turnaround retail name and as a stock that...

Air Products and Chemicals (NYSE:APD) has been selected by Samsung to supply industrial gases to Samsung's new advanced semiconductor facility in South Korea. This agreement represents APD's largest investment in the semiconductor industry and its largest electronics site globally. The partnership creates a major new operational presence for APD in South Korea, supporting global electronics manufacturing. For investors watching NYSE:APD, this development comes as the stock trades around...